Skip to content
healthcare.dev

Lubiprostone

NDC 70710-1641, Lubiprostone, capsule, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1641
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214131
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1641 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUBIPROSTONE8 ug/1

Pharmacologic classes

Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]

Package NDCNDC-11Package
70710-1641-170710164101100 CAPSULE in 1 BOTTLE (70710-1641-1)
70710-1641-67071016410660 CAPSULE in 1 BOTTLE (70710-1641-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6c11a204-6831-4269-a3c4-1702ed83f74b
  • NADAC price for package 70710164106

    GET /v1/drugs/nadac/70710164106

Use it

Look up 70710-1641 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1641 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1641. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.